CeBIL

CeBIL is the Centre for Advanced Studies in Bioscience Innovation Law based at the University of Copenhagen, Denmark. The overall aim and ambition of CeBIL is to provide solid, research-based support that facilitates the translation of world-class health and life science research into viable and sustainable products, effective therapies, and high-quality patient care. Health and life science innovations must readily and safely reach consumers, patients, and markets while simultaneously being developed in responsible, effective, sustainable, and globally competitive ways. The Centre for Advanced Studies in Bioscience Innovation Law (CeBIL) explores the legal challenges and rapid developments in the health and life science area. The center brings together scholars from the world's leading research institutions in interdisciplinary collaboration, engaging stakeholders from industry, government, and civil society. CeBIL’s scientifically independent research is supported by several public and private funds, including EU Horizon funds, Danish Research Foundation funds, Social Sciences and Humanities Research Council of Canadian Government funds as well as two generous 35 million DKK and 50 million DKK grants from the Novo Nordisk Foundation awarded in 2018 and 2023. CeBIL is managed by CeBIL Founding Director and grant holder Professor Timo Minssen (https://www.linkedin.com/in/timo-minssen-21625b36/). Follow us on social media: LinkedIn: https://www.linkedin.com/company/cebil/ X: @CeBIL_Center Facebook: https://www.facebook.com/CeBIL.Center/